All In MedTech

Device Trial Radar · NCT04016103

MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time

Last checked: Nov 19, 2026Latest source record: Feb 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

Jul 17, 2020

Primary completion

Feb 1, 2023

Study completion Jun 30, 2023

Sponsor

Lead sponsor
MY01 Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre; Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
First posted
Jul 11, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Compartment syndrome can result from extremity trauma. It can also be caused by procedural cases that involve lower or upper extremity surgery. This condition results in muscle death, chronic pain, infection, and possible amputation. Early diagnosis is essential to institute interventions that can avoid complications. Subjective pain of the patient remains the mainstay for diagnosis. A method or device is needed that would improve our accuracy in diagnosing compartment syndrome. Ideally, this would be suited for single and/or continuous pressure read-outs. The aim is to reduce the incidence of missed compartment syndrome and diminish delays that would lead to significant disability. Despite awareness, delayed diagnosis and treatment occurs in modern orthopaedic practice. As noted in many studies, once a diagnosis has been made, immediate fasciotomy is necessary to provide the best chance for a favourable clinical result. Therefore, there is a need for improved devices in order to obtain an early and reliable diagnosis.

Conditions

  • Acute Compartment Syndrome

Interventions

  • MY01 - Continuous Compartmental Pressure MonitorDevice

    Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical ease with which the new compartment pressure monitor was inserted into compartment.Time frame: 24-48 hours following device insertion
  2. Ability to monitor in real-time the continuous pressure read-out from the compartment in remote locations such as an I-phone.Time frame: 24-48 hours following device insertion
  3. The correlation of continuous pressure read-outs (high, normal or low) with clinical indications for compartment syndrome in each patient.Time frame: 24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Montreal General Hospital

    Montreal, Quebec, Canada

  • Hôpital du Sacré-Coeur de Montreal

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.